Search - Université Paris Cité Access content directly

Filter your results

11 Results
Structure: Internal structure identifier : 190544

Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme

V. Leroy , C. Hezode , S. Metivier , M. Tateo , F. Conti et al.
Journal of Hepatology, 2016, 64 (2), pp.S829. ⟨10.1016/S0168-8278(16)01622-6⟩
Journal articles hal-03590935v1
Image document

Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)

Jean-Baptiste Assié , Romain Corre , Matteo Giaj Levra , Christophe Yannick Calvet , Anne-Françoise Gaudin et al.
Therapeutic Advances in Medical Oncology, 2020, 12, ⟨10.1177/1758835920967237⟩
Journal articles hal-03018987v1
Image document

Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme

Christophe Hezode , Pascal Lebray , Victor de Ledinghen , Fabien Zoulim , Vincent Di Martino et al.
Liver International, 2017, 37 (9), pp.1314 - 1324. ⟨10.1111/liv.13383⟩
Journal articles hal-01784615v1
Image document

Defining the critical hurdles in cancer immunotherapy

Bernard Fox , Dolores Schendel , Lisa Butterfield , Steinar Aamdal , James Allison et al.
Journal of Translational Medicine, 2011, 9 (1), pp.214. ⟨10.1186/1479-5876-9-214⟩
Journal articles inserm-00691923v1

Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects

Ram Kandasamy , Todd Hillhouse , Kathryn Livingston , Kelsey Kochan , Claire Meurice et al.
Proceedings of the National Academy of Sciences of the United States of America, 2021, 118 (16), pp.e2000017118. ⟨10.1073/pnas.2000017118⟩
Journal articles hal-03241949v1

Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection

Fred Poordad , William Sievert , Lindsay Mollison , Michael A. Bennett , Edmund Tse et al.
JAMA Ophthalmology, 2015, 313 (17), pp.1728-1735. ⟨10.1001/jama.2015.3860⟩
Journal articles hal-01679637v1

Residual symptoms and functional performance in a large sample of euthymic bipolar patients in France (the OPTHYMUM study)

Ludovic Samalin , Pierre Michel Llorca , Bruno Giordana , Vanessa Milhiet , Liova Yon et al.
Journal of Affective Disorders, 2014, 159, pp.94-102. ⟨10.1016/j.jad.2014.02.023⟩
Journal articles hal-02173492v1
Image document

Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab

Christos Chouaïd , Valentine Grumberg , Alexandre Batisse , Romain Corre , Matteo Giaj Levra et al.
JCO Clinical Cancer Informatics, 2022, 6, ⟨10.1200/CCI.21.00108⟩
Journal articles hal-03559966v1

Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C

Jean-Pierre Bronowicki , Vlad Ratziu , Adrian Gadano , Paul Thuluvath , Fernando Bessone et al.
Journal of Hepatology, 2014, 61 (6), pp.1220 - 1227. ⟨10.1016/j.jhep.2014.07.011⟩
Journal articles hal-01699241v1

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

Michael Manns , Stanislas Pol , Ira Jacobson , Marc Marcellin , Stuart Gordon et al.
The Lancet, 2014, 384 (9954), pp.1597 - 1605. ⟨10.1016/S0140-6736(14)61059-X⟩
Journal articles hal-01687214v1
Image document

From single-arm studies to externally controlled studies. Methodological considerations and guidelines

Michel Cucherat , Silvy Laporte , Olivier Delaitre , Jehan-Michel Behier , Anne d'Andon et al.
Therapies, 2020, 75 (1), pp.21-27. ⟨10.1016/j.therap.2019.11.007⟩
Journal articles hal-02498637v1